Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Cash & Equivalents (2024 - 2026)

Updated

Seaport Therapeutics' Cash & Equivalents came in at $61.55 million for Q3 2026, down 4.2% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Seaport Therapeutics' Cash & Equivalents was $46.04 million, down 85.1% from FY2024.

  • Going back by year, Cash & Equivalents was $309.1 million in FY2024.
  • The five-year range for quarterly Cash & Equivalents is $46.04 million (Q4 2025) to $309.1 million (Q4 2024).
  • Business Quant data shows SPTX's Cash & Equivalents at $64.22 million (Q2 2026), $52.91 million (Q1 2026) and $46.04 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 61.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 61.55 Mn
Jun 30, 2026 64.22 Mn
Mar 31, 2026 52.91 Mn
Dec 31, 2025 46.04 Mn
Dec 31, 2024 309.10 Mn
API Access

Seaport Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SPTX&period=max&api_key=YOUR_API_KEY